Clinical Trials Logo

Advanced Adenoma clinical trials

View clinical trials related to Advanced Adenoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05875584 Completed - Colorectal Cancer Clinical Trials

Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection

Start date: May 18, 2023
Phase:
Study type: Observational

Exploration of a novel rbcDNA liquid biopsy technique for early detection of colorectal cancer is a promising development in the field of disease diagnosis and screening. This technique has the potential to establish an efficient and sensitive system for the early detection of colorectal cancer, which can provide a new perspective for individual health monitoring.

NCT ID: NCT05568992 Completed - Advanced Adenoma Clinical Trials

Prospective, Randomized Controlled Study to Evaluate the Effect of Artificial Intelligence Assisted Optical Diagnosis of Advanced Adenomas

Start date: October 6, 2022
Phase: N/A
Study type: Interventional

This study is a clinical validation of our developed a computer-aided optical dignosis of advanced adenoma using non-magnified NBI image. This study is a randomized clinical trial comparing endoscopists' optical recognition of advanced adenoma for sending to histological examination with our computer-aided system. The hypothesis of the study is that the developed computer-aided system increases the percent of sending actual advanced adenoma Intelligence Assisted Optical Diagnosis of Advanced Adenomas

NCT ID: NCT04786704 Completed - Colorectal Cancer Clinical Trials

A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population

Start date: March 22, 2021
Phase:
Study type: Observational

to determine screening value of stool-based SDC2 DNA methylation test for advanced colorectal neoplasia in the asymptomatic Chinese community population.

NCT ID: NCT04287335 Completed - Colorectal Cancer Clinical Trials

Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China

CLEAR-C
Start date: September 18, 2018
Phase:
Study type: Observational

The primary objective is to determine the diagnostic sensitivity and specificity of the newly developed multitarget FIT-DNA Colorectal Cancer (CRC) screening test (ColoClear) for detecting advanced neoplasia (including colorectal cancer and advanced adenomas) in high risk patients, using colonoscopy as the reference method. The secondary objective is to compare the screening performance of the multitarget FIT-DNA test with commercially available FIT (Fecal Immunochemical Test) assay in detecting advanced neoplasia.